Sonoma Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,172
Closed -$216K 79
2024
Q4
$216K Sell
2,172
-6,094
-74% -$628K 0.35% 75
2024
Q3
$939K Buy
8,266
+128
+2% +$15.2K 1.46% 16
2024
Q2
$1.01M Sell
8,138
-381
-4% -$49.1K 1.64% 14
2024
Q1
$1.12M Sell
8,519
-302
-3% -$37.2K 1.81% 11
2023
Q4
$962K Sell
8,821
-552
-6% -$57.3K 1.59% 15
2023
Q3
$965K Sell
9,373
-188
-2% -$20.3K 1.76% 13
2023
Q2
$1.1M Buy
9,561
+588
+7% +$66.8K 1.93% 12
2023
Q1
$955K Sell
8,973
-201
-2% -$21.7K 1.9% 15
2022
Q4
$1.02M Buy
+9,174
New +$938K 2.25% 12

Other funds holding MRK

Sonoma Private Wealth's MRK Position: Q1 2025 in Review

Sonoma Private Wealth sold out of Merck (MRK) in Q1 2025, closing a stake of 2,172 shares — an estimated $216K sold.

Sonoma Private Wealth first reported a position in MRK in Q4 2022 and held it in 9 quarters. The position peaked at $1.12M in Q1 2024. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Sonoma Private Wealth reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Sonoma Private Wealth sold 2,172 Merck shares in Q1 2025, an estimated $216K.
  • Sonoma Private Wealth first reported a position in Merck in Q4 2022 and held it in 9 quarters.
  • Sonoma Private Wealth's Merck position peaked at $1.12M in Q1 2024.
  • 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Sonoma Private Wealth's 13F filing for Q1 2025, filed 15 May 2025.